Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1134_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Foreword
- •Preface
- •Contents
- •Pain
- •Agitation-Sedation
- •Delirium
- •Contributors
- •1: Pain, Agitation, Delirium, and Immobility in the ICU
- •Introduction
- •Research Background
- •Pain, Agitation, and Delirium Assessment Scales
- •Non-pharmacological Approaches
- •Early Mobility
- •Post-intensive Care Syndrome
- •References
- •2: Bedside Neurologic Monitoring
- •Introduction
- •Cerebral Physiology Overview
- •The Neurologic Exam
- •Systemic Hemodynamic and Metabolic Monitoring
- •Continuous Electroencephalography and Electrocorticography
- •Transcranial Doppler
- •Intracranial Pressure Monitoring
- •Cerebral Oxygenation
- •Cerebral Blood Flow
- •Cerebral Microdialysis
- •Jugular Bulb Oximetry
- •Cerebrovascular Pressure Reactivity Index (PRx)
- •Brain Temperature
- •Near-Infrared Spectroscopy
- •Evoked Potentials
- •References
- •3: Status Epilepticus
- •Introduction
- •Epidemiology
- •Etiology
- •Pathophysiology
- •Neurochemical Changes
- •Physiological Changes
- •Diagnosis
- •Neurological and Physical Examination and History
- •Brain Imaging
- •Management
- •Antiepileptic Drugs in Convulsive SE
- •Antiepileptic Drugs in Nonconvulsive SE and Ictal-Interictal Patterns
- •Seizure Prophylaxis in Intracranial Pathologies
- •Traumatic Brain Injury (TBI)
- •Brain Tumors
- •Ischemic Stroke
- •Intracerebral Hemorrhage
- •Aneurysmal Subarachnoid Hemorrhage (aSAH)
- •Case Example Explanation
- •References
- •4: Traumatic Brain Injury
- •Epidemiology
- •Neurologic Severity Score
- •Anatomic Location
- •Skull Fractures
- •Intracranial Lesions
- •Focal Intracranial Lesions
- •Intraparenchymal Hemorrhage
- •Subdural Hematoma
- •Epidural Hematoma
- •Subarachnoid Hemorrhage
- •Diffuse Intracranial Lesions
- •Diffuse Axonal Injury
- •Abdominal Decompression
- •Special Populations
- •Diffuse Axonal Injury
- •Management of Skull Fractures
- •Management of Concussion
- •Outcomes
- •Glasgow Outcomes Score (GOS)
- •Brain Death Exam/Determination
- •References
- •5: Care of the Spinal Cord-Injured Patient
- •Epidemiology
- •Clinical Assessment
- •Physical Exam
- •Imaging
- •Clearing the Cervical Spine
- •Intensive Care Management
- •Cardiovascular Complications
- •Respiratory Complications
- •Physiologic Respiratory Changes After Spinal Cord Injury
- •Concussion
- •Primary and Secondary Brain Injury
- •Evaluation
- •Physical Examination
- •Neurologic Examination
- •Imaging
- •CT Scan
- •CT Angiography
- •Magnetic Resonance Imaging
- •Monitoring
- •Intracranial Pressure Monitoring
- •Internal ICP Monitoring
- •External ICP Monitoring
- •Brain Tissue Oxygen (PbtO2) Monitoring
- •Management
- •Medical Management
- •Pathophysiology of Cerebral Perfusion
- •Reduction of ICP
- •Hypertonic Saline
- •Mannitol
- •Hyperventilation
- •Elevation of the Head of the Bed
- •Optimization of Systemic Blood Pressure and Oxygenation
- •Pharmacologic Management of TBI
- •Seizure Prophylaxis
- •Venous Thromboembolism (VTE) Prophylaxis
- •Therapeutic Hypothermia
- •Nutrition
- •Surgical Management
- •Management of Hematomas
- •Decompressive Craniotomy/Craniectomy
- •Burr Holes/Emergency Craniostomy
- •Ventilator Management in Patients with SCI
- •Deep Venous Thrombosis and Venous Thromboembolism (VTE)
- •Glucocorticoid Use in Acute SCI
- •Nutrition and Glycemic Control
- •Ethics/End of Life
- •References
- •6: Nontraumatic Neurological Conditions
- •Major Ischemic Stroke Syndromes
- •General Management of Ischemic Stroke
- •Malignant Middle Cerebral Artery Stroke
- •Basilar Strokes
- •Cerebellar Stroke
- •Cerebral Venous Thrombosis
- •Primary Intracerebral Hemorrhage
- •Aneurysmal Subarachnoid Hemorrhage
- •Hypoxic and Anoxic Brain Injury
- •CNS Infections
- •Acute Bacterial Meningitis
- •Acute Encephalitis
- •Brain Abscesses
- •Malignant Brain Tumors
- •References
- •7: Hemodynamic Monitoring and Resuscitation
- •Introduction
- •Injury Stress and Fluid Loss
- •Measuring Hypovolemia
- •Invasive Blood Pressure Monitoring
- •Central Venous Pressure
- •Pulmonary Artery Occlusion Pressure
- •Dynamic Measures of Fluid Responsiveness
- •Esophageal Doppler
- •Pulse Pressure/Stroke Volume Variability (PPV/SVV)
- •Pulse Contour Cardiac Output
- •LiDCO
- •PiCCO
- •End-Expiratory Occlusion (EEO)
- •Passive Leg Raising
- •Echocardiography
- •The Current Role of Echocardiography in Critical Care
- •Ventricular Function
- •Assessments of Cardiac Output (CO)
- •Volume Status
- •Goal-Directed Resuscitation
- •Lactate and Lactate Clearance
- •Blood Transfusion
- •Current Status of Transfusion Therapy
- •References
- •8: Hemodynamic Monitoring in Surgical Critical Care
- •Introduction
- •Indirect Perfusion Measurement
- •Considerations: Auscultation/Manual Method
- •Considerations: Oscillometric/Automated Method
- •Gastric pH Monitoring
- •Considerations
- •Sublingual Capnography
- •Considerations
- •Central Venous Pressure Monitoring
- •Considerations
- •Pulmonary Catheter Monitoring
- •Considerations
- •Tissue Oxygenation
- •Tissue Oxygenation: VO2
- •Considerations
- •Tissue Oxygenation: Mixed Venous O2 Saturation (SvO2)
- •Considerations
- •Tissue Oxygenation: Central Venous O2 Saturation (ScvO2)
- •Direct Perfusion Measurement
- •Considerations
- •Direct Visualization Methods
- •Transthoracic Echocardiography
- •Image Acquisition
- •Examination Views
- •Image Interpretation
- •Considerations
- •Transesophageal Echocardiography
- •Image Acquisition and Interpretation
- •Considerations
- •References
- •9: Cardiovascular Emergencies
- •Introduction
- •Acute MI
- •Management: STEMI
- •Management: NSTEMI
- •Acute Pulmonary Embolism
- •Tamponade
- •Tension Pneumothorax
- •Aortic Dissection
- •Traumatic Aortic Injury
- •Mechanical Complications of MI: Ventricular Septal Defect and Free Wall Rupture
- •Mechanical Complications of MI: Left Ventricular Aneurysm
- •Mechanical Complications of MI: Papillary Muscle Rupture and Acute Mitral Regurgitation
- •Future Horizons: The Emerging Role of Extracorporeal Life Support in Cardiovascular Emergencies
- •References
- •Introduction
- •Physiologic Basis of Therapy
- •The Circuit
- •Components
- •Patient Selection
- •Supporting Literature
- •Hypoxemic Respiratory Failure
- •Hypercarbic Respiratory Failure
- •Bridge-to-Lung Transplant
- •Cardiac Failure
- •Management of ECMO
- •Patient Management
- •Circuit Management
- •Multidisciplinary Team
- •Outcomes
- •Survival
- •Complications
- •Long-Term Outcomes
- •Future Applications
- •Conclusion
- •Additional Resources
- •References
- •11: Acute Respiratory Distress Syndrome and Lung Protective Ventilation
- •Introduction
- •Approach to MV in ARDS
- •Alternate Approaches to MV
- •Nonventilatory Adjuncts to MV
- •Intraoperative MV: A Setup for Disaster?
- •Summary
- •References
- •12: Noninvasive Ventilation in the Perioperative Period
- •Introduction and Physiology
- •Continuous Positive Airway Pressure (CPAP)
- •Bilevel Positive Airway Pressure (BPAP)
- •Rationale and Epidemiology
- •Equipment
- •Interface
- •Equipment Complications
- •Pressure Ulceration
- •Patient-Ventilator Dyssynchrony
- •Patient Selection
- •Early Recognition of NIV Failure
- •Protocol for Initiating NIV
- •Preoperative NIV
- •NIV for Pre-oxygenation During Anesthetic Induction
- •Postoperative NIV
- •Abdominal Surgery
- •Foregut Surgery
- •Thoracic Surgery
- •Injured Patients
- •Obstructive Sleep Apnea
- •Perioperative OSA Risk Assessment
- •Immunocompromised Patients
- •Post-extubation Respiratory Failure
- •Palliative NIV
- •References
- •13: Care of the Surgical ICU Patient with Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension
- •Chronic Obstructive Pulmonary Disease
- •Overview and Epidemiology
- •Pathophysiology and Etiology
- •Initial Evaluation
- •Clinical Symptoms and Physical Exam
- •Indications for ICU Admission
- •Differential Diagnosis and Diagnostic Workup
- •Pharmacotherapeutic Management
- •Glucocorticoids
- •Bronchodilators
- •Antibiotics
- •Ventilatory Support
- •Airway Clearance Techniques
- •Oxygen
- •Noninvasive Ventilation
- •Mechanical Ventilation
- •Ventilator Weaning, Consideration of Tracheostomy, and Palliative Care
- •Pulmonary Hypertension
- •Pathophysiology of Right Ventricular Failure
- •Etiology and Prognosis
- •Clinical Presentation
- •Diagnostic Evaluation
- •Management Considerations
- •Clinical Monitoring
- •Preload Optimization
- •Afterload Optimization
- •Vasoactive Therapies
- •Rhythm Control
- •Oxygenation and Ventilatory Support
- •Advanced Therapies
- •Palliative Care and End of Life
- •Pre-, Peri-, and Postoperative Management Considerations
- •References
- •14: Diagnosis and Management of Acute Kidney Injury
- •Introduction
- •Epidemiology of AKI
- •Causes of AKI
- •Early Recognition and Initial Management
- •Investigations
- •Subcellular Events: Current Theories
- •Supportive Care and Medical Management of Complications
- •Intravenous Fluids and Hemodynamic Support
- •Diuretics
- •Vasodilators and Other Pharmacologic Agents
- •Nutritional Support
- •Long-Term Follow-Up
- •References
- •15: Renal Replacement Therapy in the Critically Ill Surgical Patient
- •Introduction
- •Overview of Modalities
- •Hemodialysis (Diffusive Clearance)
- •Intermittent Hemodialysis
- •Continuous Modalities
- •Continuous Venovenous Hemodialysis (CVVHD)
- •Hybrid Therapy: SLED
- •Overview of Controversies
- •Dose
- •Mode
- •Timing
- •Clinical Considerations
- •Access
- •Anticoagulation
- •Special Considerations
- •Discontinuation of Therapy
- •Emerging Concepts
- •References
- •16: Gastrointestinal Hemorrhage
- •Introduction
- •Upper Gastrointestinal Hemorrhage
- •Peptic Ulcer Disease (PUD)
- •Esophagitis
- •Stress-Related Mucosal Disease (SRMD)
- •Zollinger-Ellison Syndrome (ZES)
- •Vascular Lesions
- •Mallory-Weiss Tear
- •Tumors
- •Injury
- •Post-intervention and Postsurgical
- •Other
- •Guideline-Derived Recommendations
- •Variceal Hemorrhage
- •Hepatic Transplantation
- •Small Bowel Hemorrhage
- •Lower GI Hemorrhage (LGIH)
- •References
- •17: Critical Care Management of Severe Acute Pancreatitis
- •Introduction
- •Epidemiology
- •Etiology
- •Diagnosis
- •Clinical Presentation
- •Laboratory Tests
- •Imaging Studies
- •Overall Diagnosis
- •Clinical Scoring Systems
- •Ranson’s Criteria
- •APACHE II
- •BISAPS
- •Computed Tomography Scoring Systems
- •Phases of Acute Pancreatitis
- •Organ Failure
- •Types of Acute Pancreatitis
- •Systemic and Local Complications
- •Predicting Severe Acute Pancreatitis
- •ICU Management
- •Management in the First 24–48 h
- •Initial Resuscitation
- •Volume of Resuscitation
- •Guidance of Resuscitation
- •Resuscitation Fluid Type
- •Vasopressor and Inotropic Support
- •Intra-abdominal Hypertension and Abdominal Compartment Syndrome
- •Continuous Renal Replacement Therapy
- •Strategy for Management in the First 24 h
- •Management in the First Week
- •Nutritional Support
- •Enteral Nutrition
- •Location of Enteral Feeding
- •Antibiotics and Probiotics in the Prevention of Infected Necrosis
- •Prophylactic Antibiotics
- •Probiotics
- •The Role of Acute Endoscopic Therapy
- •Overall Management Strategy in the First Week
- •ICU Management After the First Week
- •Management of Sterile and Infected Necrosis
- •Utility of Fine Needle Aspiration
- •Antibiotic Therapy for Infected Necrosis
- •Interventional Treatment for Infected Necrosis
- •Disconnected Pancreatic Duct Syndrome and Pancreatic Fistula
- •Gastrointestinal Complications of Severe Acute Pancreatitis
- •Vascular Complications of Acute Pancreatitis
- •Portosplenomesenteric Venous Thrombosis
- •Hemorrhage and Pseudoaneurysm
- •Strategy for Management After the First Week
- •Summary
- •References
- •18: Hepatic Failure
- •Acute Liver Failure
- •Clinical Manifestations
- •Neurologic System
- •Respiratory System
- •Cardiovascular and Hematologic System
- •Gastrointestinal and Endocrine Systems
- •Renal System and Electrolytes
- •Infectious Disease
- •Other Systems
- •Workup and Initial Management
- •Management
- •Encephalopathy, Cerebral Edema, and Intracranial Hypertension
- •Respiratory Management
- •Cardiovascular and Hematologic Management
- •Gastrointestinal and Endocrine Management
- •Renal Management
- •Infectious
- •Acetaminophen Toxicity
- •Amatoxin Intoxication
- •Wilson’s Disease
- •Viral Hepatitis
- •Ischemic Hepatitis
- •Chronic Liver Disease
- •Clinical Manifestations
- •Nervous System
- •Respiratory System
- •Cardiovascular and Hematologic System
- •Gastrointestinal and Endocrine Systems
- •Renal System
- •Infectious Disease
- •Other Systems
- •Workup and Initial Management
- •Management
- •Encephalopathy
- •Ascites
- •Spontaneous Bacterial Peritonitis
- •Variceal Hemorrhage
- •Hepatorenal Syndrome
- •Liver Transplantation
- •Other Therapies
- •References
- •19: Abdominal Compartment Hypertension and Abdominal Compartment Syndrome
- •Introduction
- •Diagnosis: Physiologic Markers of ACS
- •Diagnosis: Measurement of Abdominal Pressure
- •Treatment
- •Management of the Open Abdomen
- •Closure of the Open Abdomen
- •References
- •20: Nutrition in the Surgical ICU Patient
- •Introduction
- •Nutrition Assessment
- •Energy and Protein Requirements
- •Preoperative Period
- •Route of Nutrition
- •Enteral Nutrition
- •Immunonutrition
- •EN Access
- •Protocolized Management of EN
- •EN in Complex Situations
- •New Anastomosis
- •Postoperative Ileus
- •Vasopressor Support
- •Traumatic Brain Injury
- •Temporary Abdominal Closure
- •Parenteral Nutrition
- •Oral Diet
- •Probiotics
- •References
- •21: Antibiotic Strategy and Stewardship
- •Preventing Resistance
- •Antibiotic Formulary Restriction
- •Antibiotic Cycling
- •Preventing Infection
- •General Control Measures
- •Handwashing and Barrier Precautions
- •Decolonization
- •Health-Care-Associated Infections
- •Central Line-Associated Bloodstream Infection
- •CAUTI
- •De-escalation
- •References
- •22: Sepsis, Severe Sepsis, and Septic Shock
- •Introduction
- •Epidemiology
- •Risk Factors
- •Sepsis Syndromes
- •Quantifying Organ Dysfunction in Severe Sepsis and Septic Shock
- •Biomarkers in Sepsis
- •Markers of Tissue Hypoperfusion
- •Treatment of Severe Sepsis, Septic Shock, and Organ Dysfunction
- •Early Goal-Directed Therapy
- •Fluid Resuscitation in Sepsis
- •Invasive Hemodynamic Monitoring
- •Antimicrobial Therapy
- •Source Control
- •Damage Control in Intra-abdominal Sepsis
- •Cardiovascular Support
- •Corticosteroids
- •Transfusions
- •Coagulation Disorders in Septic Shock
- •Activated Protein C
- •Acute Kidney Injury and Septic Shock
- •ARDS and Sepsis
- •Neurologic Dysfunction in Severe Sepsis
- •Multi-organ Dysfunction Syndrome
- •References
- •23: Source Control and Supporting Therapeutics: Integrating Bacterial Invasion, Host Defense, and Clinical Interventions with Source Control Procedures
- •Introduction
- •Source Control
- •Changes in Source Control Procedures
- •Source Control and Clinical Trials
- •Source Control Issues Related to Pathogens
- •Bacterial Invasion and Multidrug-Resistant Organisms (MDRO)
- •Organism Virulence Factors
- •Source Control Issues Related to the Host
- •Metabolic Derangements
- •Plasma Volume Expansion
- •Organ Failure
- •Immunonutrition and Immunomodulation
- •Epigenetic Phenomena and Receptor-Ligand Interactions
- •References
- •24: Soft Tissue Infections
- •Introduction
- •Pathogenesis of SSTI
- •Non-necrotizing SSTI
- •Epidemiology
- •Treatment of Non-necrotizing SSTI
- •Non-necrotizing Cellulitis
- •Bite Wounds
- •Complicated Abscesses
- •Necrotizing SSTI
- •Epidemiology, Bacteriology, and Outcome of NSSTI
- •Therapeutic Considerations in NSSTI
- •Type 2 NSSTI
- •Type 3 NSSTI
- •Type 1 NSSTI
- •Diagnosis of NSSTI
- •Therapeutic Approach for NSSTI
- •Surgical Therapy for NSSTI
- •Antibiotic Therapy for NSSTI
- •Incisional Surgical Site Infections
- •Pathogenesis of SSI
- •Therapeutic Approach for SSI
- •References
- •25: Anemia in the Surgical ICU
- •Epidemiology of Anemia in the ICU
- •Pathophysiology
- •Oxygen Delivery and Consumption
- •Red Blood Cell Life Span and Regulation of Red Cell Mass
- •Mechanisms of Compensation
- •Mechanisms of Anemia in Critical Care
- •RBC Loss
- •Impaired Erythropoiesis: Reduced RBC Production and Shortened RBC Life Span
- •Iron Homeostasis and Hepcidin
- •Hemodilution
- •Management/Treatment of Anemia
- •Transfusion Indications in the ICU
- •Risks of Transfusions
- •TRALI
- •TACO
- •TRIM
- •Anemia After ICU Care
- •References
- •26: Coagulopathies and Anticoagulation
- •Introduction
- •Assessing the Coagulopathic Patient
- •Common Acquired and Medication-Induced Coagulopathies in the ICU
- •Liver Disease
- •Acute Traumatic Coagulopathy
- •Post Cardiopulmonary Bypass
- •Pregnancy
- •Antiphospholipid Syndrome
- •Heparin and LMWH
- •Warfarin
- •Novel Anticoagulants
- •Inherited Coagulopathies in the ICU
- •Von Willebrand Disease
- •Hemophilia A and B
- •Procoagulant Therapies
- •Anticoagulation Management in the ICU
- •VTE Chemoprophylaxis or Full Anticoagulation in Patients with Blunt Solid Organ Injury
- •VTE Chemoprophylaxis or Full Anticoagulation in Patients with Traumatic Brain Injury
- •Atrial Fibrillation ATE Prevention
- •ICU Procedures in Patients with Coagulopathy and Therapeutic Anticoagulation
- •Mechanical Heart Valves
- •Pulmonary Embolism with an Absolute Contraindication to Anticoagulation
- •Presumed Pulmonary Embolism in a Patient with Hemodynamic Instability or Cardiac Arrest
- •Summary
- •References
- •27: Thrombocytopenia in the Surgical Intensive Care Unit
- •Introduction
- •Clinical Presentation
- •Etiologies of Thrombocytopenia in the ICU
- •Decreased Production
- •Increased Destruction, Consumption, or Dilution of Platelets
- •Sepsis and Disseminated Intravascular Coagulation
- •Heparin-Induced Thrombocytopenia (HIT)
- •Other Drug-Induced Hemolytic-Thrombolytic Syndromes
- •Immune Thrombocytopenia (ITP)
- •Thrombotic Microangiopathies (TMA)
- •Intravascular Hemolysis
- •Postsurgical Thrombocytopenia
- •Trauma-Induced Coagulopathy (TIC)
- •Sequestration
- •Evaluation of Thrombocytopenia
- •Treatment
- •References
- •28: Venous Thromboembolism in the Intensive Care Unit
- •Introduction
- •Incidence
- •Risk Factors and Risk Assessment
- •Prevention
- •Pharmacologic Prophylaxis
- •Mechanical Prophylaxis
- •Prophylactic Inferior Vena Cava Filters
- •Prescription and Administration Compliance
- •Diagnosis
- •Duplex Ultrasonography
- •Computed Tomography Angiography
- •Echocardiography
- •Other Diagnostic Modalities
- •Screening in Asymptomatic Patients
- •Treatment of DVT
- •Treatment of PE
- •Impact
- •References
- •29: Glycemic Control and Insulin Resistance
- •Overview of Evidence Supporting Strict Glucose Control in the ICU
- •Resolving the Differences Between Studies of Intensive Glucose Control
- •The Role of Hypoglycemia and Glucose Variability in ICU Mortality
- •What Is the Appropriate Target for Glucose Control?
- •Glucose Measurement in the ICU
- •Recent Technological Developments
- •References
- •30: Critical Illness-Related Corticosteroid Insufficiency in the Intensive Care Patient
- •Introduction
- •Physiology of the HPA Axis
- •The Systemic Effects of Cortisol
- •Cortisol Synthesis
- •Critical Illness
- •Diagnosing CIRCI
- •Cortisol Levels
- •ACTH Stimulation Tests
- •Evidence for Treatment
- •Therapy
- •Perioperative “Stress Dose” Steroids
- •Steroids in Acute Respiratory Distress Syndrome (ARDS)
- •Summary
- •References
- •31: Thyroid Disorders
- •Introduction
- •Epidemiology
- •Thyroid Storm
- •Pathophysiology
- •Precipitating Causes
- •Clinical Features and Diagnosis
- •Medical Treatment
- •Therapeutic Plasma Exchange
- •Thyroid Surgery
- •Thyroid Storm in Pregnancy
- •Long-Term Management of Hyperthyroidism
- •Outcomes of Thyroid Storm
- •Myxedema Coma
- •Clinical Features and Diagnosis
- •Treatment
- •Myxedema Coma in Pregnancy
- •References
- •32: Hyperadrenergic Crisis
- •Introduction
- •Clinical Presentation
- •Signs and Symptoms by Organ System
- •Hypertension, Hypotension, and Shock
- •Cardiac
- •Pulmonary
- •Peripheral Vasculature
- •Gastrointestinal
- •Renal
- •Neurologic
- •Multiple Organ System Failure
- •Misdiagnosis
- •Pathogenesis
- •Pathophysiology
- •Precipitants
- •Diagnosis
- •Biochemical Diagnosis
- •Imaging
- •Management
- •Immediate Management
- •Medications
- •Hypotension and Circulatory Support
- •Timing of Surgery
- •Operative Management
- •Postoperative Care
- •References
- •33: Trauma
- •General Approach
- •Initial Assessment
- •Airway
- •Breathing
- •Circulation
- •Disability
- •Environment/Exposure
- •Early and Later Stages of ICU Care
- •Neurologic
- •Pulmonary
- •Cardiovascular
- •Renal/Electrolytes
- •Gastrointestinal/Nutrition
- •Hematology
- •Infectious Disease
- •Endocrine
- •Musculoskeletal
- •Tubes/Lines and Drains
- •Special Considerations
- •Damage Control Abdomen
- •Transport
- •ICU as an OR
- •Family Support/Interaction
- •End of Life/Gift of Life
- •References
- •34: Immunocompromised Patients
- •Introduction
- •Solid Organ Transplant Recipients
- •Overview of Infectious Risks and Initial Diagnostic Evaluation
- •Empiric Therapy
- •Chemotherapy, Radiation, and Stem Cell Transplant Recipients
- •Neutropenic Patients
- •Overview of Infectious Risks
- •Initial Diagnostic Evaluation
- •Empiric Therapy
- •Stem Cell Transplantation Recipients
- •Overview of Infectious Risks and Initial Diagnostic Evaluation
- •Empiric Therapy
- •Patients Receiving Chronic Corticosteroids
- •Overview of Infectious Risks
- •Initial Diagnostic Evaluation
- •Empiric Therapy
- •Patients Receiving TNF-α (Alpha) Inhibitor Therapy
- •Overview of Infectious Risks
- •Initial Diagnostic Evaluation
- •Empiric Therapy
- •Patients with HIV/AIDS
- •Overview of Infectious Risks and Initial Diagnostic Evaluation
- •Empiric Therapy
- •Antiretroviral (ARV) Use in the ICU
- •Patients with Chronic Hepatitis B or C Infection
- •Overview of Infectious Risks
- •Initial Diagnostic Evaluation
- •Empiric Therapy
- •References
- •35: Transplantation
- •Introduction
- •Cardiovascular
- •Pulmonary
- •Assessment of Graft
- •Imaging
- •Renal
- •Central Nervous System
- •Infectious Disease
- •Immunosuppression
- •References
- •36: Intensive Care in Obstetrics
- •Introduction
- •Scope of the Problem
- •Maternal Morbidity and Mortality
- •Predictors of Mortality at Admission
- •Physiologic Changes in Obstetrics and Clinical Implications
- •Cardiovascular
- •Invasive Central Monitoring
- •Pulmonary
- •Hematologic
- •Renal
- •Gastrointestinal
- •Pathology in Pregnancy
- •Cardiac
- •Preeclampsia-Eclampsia
- •Hemorrhage
- •Amniotic Fluid Embolism
- •Trauma Management
- •Primary Survey
- •Secondary Survey
- •Perimortem Cesarean Section
- •Summary
- •References
- •37: The Pediatric Patient Cared for in the Adult ICU
- •Initial Resuscitation of the Pediatric Intensive Care Patient
- •Physiology of Shock
- •Broselow™ System
- •Pediatric Airway Management
- •Anatomic Considerations
- •Basic Airway Management
- •Advanced Airway Management
- •Endotracheal Intubation Considerations
- •Fluid Resuscitation
- •Pediatric Traumatic Brain Injury
- •Pediatric Analgesia and Sedation
- •General Approach
- •Medication Dosing
- •ICU Procedural Considerations
- •Central Venous Access
- •Intraosseous Access
- •Arterial Access
- •Intubation
- •Tube Thoracostomy
- •Ultrasound
- •Indications for ECMO
- •Psychosocial Considerations in Pediatric Intensive Care
- •The Adult ICU Patient with Congenital Disease (Pediatric Disease)
- •Pulmonary Considerations
- •Cystic Fibrosis
- •Respiratory Complications
- •Gastrointestinal Complications
- •Cardiac Considerations
- •Congenital Heart Disease
- •Cardiac Arrhythmia
- •Heart Failure
- •Cardiopulmonary
- •Acute Kidney Injury
- •Hepatic Dysfunction
- •Hematologic
- •Neurologic Considerations
- •VP Shunt Complications
- •References
- •38: Organ Donor Management
- •History of Organ Donation
- •Identifying Potential Donors
- •Referral of Potential Donors
- •Team Management Approaches to Donation
- •Neurological Criteria for Determination of Death
- •Donation After Circulatory Determination of Death
- •Pathophysiology of Brain Death
- •Systemic Sequelae of Brain Death
- •Cardiovascular System
- •Pulmonary System
- •Renal System
- •Hepatic System
- •Coagulation and Thermoregulation Disorders
- •The Role of Protocols in Organ Donation
- •Aggressive Resuscitation of Potential Donors
- •Hemodynamic Monitoring
- •Aggressive Hemodynamic Management
- •The Role of Vasopressin
- •The Role of Thyroxine
- •The Role of Insulin
- •The Role of Steroids
- •Managing Potential Complications
- •Considerations During Organ Recovery
- •References
- •39: Biostatistics for the Intensivist: A Clinically Oriented Guide to Research Analysis and Interpretation
- •Introduction
- •The Basic Mechanics of a Research Study
- •Power and Sample Size
- •Type III Error
- •Bias
- •Study Types
- •Measures of Disease Association
- •Relative Risk
- •Odds Ratio
- •Statistical Testing
- •Statistical Testing and Types of Data: Discrete Variables
- •Statistical Testing with Discrete Variables
- •Statistical Testing and Types of Data: Continuous Variables
- •Continuous Data: Mean, Median, Mode, and Related Concepts
- •Continuous Data: Statistical Distributions
- •Continuous Data: Standard Deviation (σ) and Standard Error of the Mean (SEM)
- •Statistical Testing with Continuous Data
- •Evaluating Diagnostic Tests
- •Measuring Agreement
- •Survival Analysis
- •Brief Comment on Trends and Pattern Analysis
- •References
- •40: Administration
- •Introduction
- •Structure
- •Personnel
- •Guidelines
- •Quality Care
- •Costs
- •Communication
- •Role of the Surgeon
- •Leadership
- •Intensivist Compensation
- •Measuring Success
- •References
- •41: Practical Pharmacokinetics and Pharmacodynamics
- •Introduction
- •Pharmacokinetics
- •Changes in Pharmacokinetics in Surgical ICU Patients
- •Pharmacodynamics
- •Pharmacokinetic/Pharmacodynamic Modeling
- •Drug Classes
- •Nondepolarizing Neuromuscular Blockers
- •Opiates
- •Sedatives
- •Anticoagulants
- •Proton Pump Inhibitors
- •Levetiracetam and Lacosamide
- •Therapeutic Drug Monitoring
- •References
- •42: Ethics and the ICU
- •Introduction
- •Withdrawing and Withholding
- •Futility
- •Advance Directives/POLST
- •Dialysis
- •Organ Donation
- •Suggested Reading
- •43: Disaster Management and Preparedness
- •Introduction
- •Epidemiology of Disasters
- •Biological Agents
- •Routes of Exposure
- •Prophylaxis and Therapy
- •Chemical Agents
- •Nerve Agents
- •Vesicants
- •Hydrogen Cyanide
- •Pulmonary Agents
- •Riot Control Agents (Tear Gases or Lacrimators)
- •Radioactive Agents
- •Medical Effects of Ionizing Radiation
- •Treatment of Radiation Casualties
- •Decontamination
- •Principles of Disaster Response
- •Principle #1
- •Principle #2
- •Principle #3
- •Disaster Medical Response
- •Search and Rescue
- •Disaster Triage
- •Levels of Triage
- •Level 1: Field Triage
- •Level 2: Medical Triage
- •Level 3: Evacuation Triage
- •Triage Errors
- •Evacuation
- •Disaster Management Teams
- •Disaster Drills
- •Summary
- •References
- •44: Postoperative Complications Following Surgery Abroad
- •Introduction
- •Elective Surgery Abroad
- •An Unregulated Industry
- •Nosocomial and Travel-Related Postoperative Infection
- •Transplant Tourism
- •Cosmetic Surgery
- •Surgical Complications in the Context of Disaster Medicine
- •Surgical Infections in Disaster Response
- •Strategies in Patient Management
- •References
- •45: Post-intensive Care Syndrome (PICS)
- •Introduction
- •Physical Impairment
- •Physical Dysfunction
- •Pulmonary Dysfunction
- •Neuromuscular Dysfunction
- •ICU-Acquired Weakness
- •Critical Illness Polyneuropathy
- •Critical Illness Myopathy
- •Risk Factors

Contents
xiii
35 Transplantation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 407
Adam S. Bodzin and Ronald W. Busuttil
36 Intensive Care in Obstetrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 417
Corrina Oxford and Mauricio La Rosa
37 The Pediatric Patient Cared for in the Adult ICU . . . . . . . . . . . . . . . . . . . . . . . . . 431
Z o ё Maher and Michael L. Nance
38 Organ Donor Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 443
Olubode Ademola Olufajo and Ali Salim
39 Biostatistics for the Intensivist: A Clinically Oriented Guide
to Research Analysis and Interpretation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 453
Heidi H. Hon , Jill C. Stoltzfus , and Stanislaw P. Stawicki
40 Administration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 465
Samuel A. Tisherman
41 Practical Pharmacokinetics and Pharmacodynamics . . . . . . . . . . . . . . . . . . . . . . 473
Anthony T. Gerlach and Lina Saliba
42 Ethics and the ICU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 483
Christine C. Toevs
43 Disaster Management and Preparedness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 487
Susan Miller Briggs
44 Postoperative Complications Following Surgery Abroad . . . . . . . . . . . . . . . . . . . 495
Nicole Lucas and William A. Walters
45 Post-intensive Care Syndrome (PICS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 501
Jed Wolpaw , Stephanie Cha , and Todd Dorman
46 Operative Procedures in the Intensive Care Unit . . . . . . . . . . . . . . . . . . . . . . . . . 515
Greta L. Piper
47 Anesthesia-Related Issues in the ICU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 521
Mark-Alan Pizzini and Benjamin L. Rubin
48 Incorporating Advanced Practice Practitioners in the ICU . . . . . . . . . . . . . . . . . 533
Ruth Kleinpell and W. Robert Grabenkort
49 Contemporary ICU Design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 539
Diana C. Anderson and Neil A. Halpern
50 Telemedicine for the Intensive Care Unit . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 551
Ann Marie Huffenberger , Niels Douglas Martin , and C. William Hanson III
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 561

Contributors
Valerianna Amorosa , MD Department of Medicine , Perelman School of Medicine,
University of Pennsylvania , Philadelphia , PA , USA
Diana C. Anderson , MD, MArch Internal Medicine , Columbia University Medical Center,
New York-Presbyterian Hospital , New York , NY , USA
Judith A. Anesi , MD Department of Medicine , Hospital of the University of Pennsylvania ,
Philadelphia , PA , USA
Sofya H. Asfaw , MD Division of Traumatology, Surgical Critical Care,
and Emergency Surgery , Perelman School of Medicine at the University of Pennsylvania ,
Philadelphia , PA , USA
Christopher R. Becker , DL. Department of Neurology , Hospital of the University
of Pennsylvania , Philadelphia , PA , USA
Adam S. Bodzin , MD Department of Surgery, Section of Transplantation ,
University of Chicago , Chicago , IL , USA
Susan Miller Briggs , MD, MPH Department of surgery, Harvard Medical School,
International Trauma and Disaster Institute , Massachusetts General Hospital ,
Boston , MA , USA
Ronald W. Busuttil , MD, PhD Department of Surgery , University of California ,
Los Angeles , CA , USA
Jeremy W. Cannon , MD, SM Division of Traumatology, Surgical Critical
Care & Emergency Surgery , Penn Presbyterian Medical Center , Philadelphia , PA , USA
Stephanie Cha , MD Anesthesiology and Critical Care Medicine , Johns Hopkins Hospital ,
Baltimore , MD , USA
D. Benjamin Christie III , MD, FACS Department of Trauma/Critical Care ,
Medical Center Navicent Health/Mercer University School of Medicine , Macon , GA , USA
Kevin K. Chung , MD Burn Center , US Army Institute of Surgical Research ,
Fort Sam Houston , TX , USA
Craig M. Coopersmith , MD Department of Surgery , Emory University Hospital ,
Atlanta , GA , USA
Molly R. Deane , MD R Adams Cowley Shock Trauma Center , University of Maryland
Medical Center , Baltimore , MD , USA
Jose J. Diaz , MD Acute Care Surgery , R. Adams Cowley Shock Trauma Center,
University of Maryland School of Medicine , Baltimore , MD , USA
Todd Dorman , MD Anesthesiology and Critical Care Medicine , Johns Hopkins Hospital ,
Baltimore , MD , USA
xv

xvi
Rebecca E. Duncan , MD Family Medicine and Surgical Critical Care,
R Adams Cowley Shock Trauma Center , University of Maryland Medical Center ,
Baltimore , MD , USA
Heather L. Evans , MD, MS, FACS General Surgery , University of Washington ,
Seattle , WA , USA
Douglas L. Fraker , MD Department of Surgery , University of Pennsylvania ,
Philadelphia , PA , USA
Andrew C. Gaugler , DO DeWitt Daughtry Family Department of Surgery ,
Jackson Memorial Hospital, Ryder Trauma Center , Miami , FL , USA
Anthony T. Gerlach , PharmD, BCPS, FCCP, FCCM Department of Pharmacy ,
The Ohio State University Wexner Medical Center , Columbus , OH , USA
Emily Jean Gilmore , MD Neurocritical Care and Emergency Neurology ,
Yale New Haven Hospital , New Haven , CT , USA
W. Robert Grabenkort , PA, MMSC, FCCM NP/PA Critical Care Residency Program ,
Emory Healthcare, Emory Critical Care Center , Atlanta , GA , USA
Scott B. Grant , MD, MBE General Surgery , Robert Wood Johnson University Hospital ,
New Brunswick , NJ , USA
Contributors
Sarah E. Greer , MD, MPH Managing Director, Institute for Trauma Research and Injury
Prevention , Princeton , NJ , USA
Oscar D. Guillamondegui , MD, MPH Department of Surgery , Vanderbilt University
Medical Center , Nashville , TN , USA
Nader M. Habashi , MD Department of Medicine, R Adams Cowley Shock Trauma Center ,
Baltimore , MD , USA
Neil A. Halpern , MD, MCCM, FACP, FCCP Critical Care Medicine Service,
Department of Anesthesiology and Critical Care Medicine , Memorial Sloan Kettering
Cancer Center , New York , NY , USA
C. William Hanson III , MD Perelman Center for Advanced Medicine ,
Hospital of University of Pennsylvania, University of Pennsylvania Health System ,
Philadelphia , PA , USA
Elliott R. Haut , MD, PhD Department of Surgery , The Johns Hopkins University
School of Medicine and Johns Hopkins University Bloomberg School of Public Health ,
Baltimore , MD , USA
Heidi H. Hon , MD Department of Surgery , St. Luke’s University Hospital ,
Bethlehem , PA , USA
Jiri Horak , MD Department of Anesthesiology and Critical Care ,
Hospital of the University of Pennsylvania , Philadelphia , PA , USA
Brett M. Howard , MD Department of Surgery , Medical Center of Navicent Health ,
Macon , GA , USA
Ann Marie Huffenberger , DBA PENN E-LERT Telemedicine Program ,
The Hospital of the University of Pennsylvania , Philadelphia , PA , USA
Juliane Jablonski , DNP, RN, CCRN, CCNS Surgical Critical Care ,
Hospital of the University of Pennsylvania , Philadelphia , PA , USA
Matthew T. James , MD, PhD Department of Medicine , Foothills Medical Center ,
Calgary , Alberta , Canada

Contributors
xvii
Lewis J. Kaplan , MD, FACS, FCCM, FCCP Department of Surgery , Perelman School
of Medicine, University of Pennsylvania, Corporal Michael J. Crescenz VA Medical Center ,
Philadelphia , PA , USA
Stacey M. Kassutto , MD Pulmonary, Allergy & Critical Care , Hospital of the University
of Pennsylvania , Philadelphia , PA , USA
Margit Kaufman , MD Anesthesiology and Critical Care Medicine , Englewood Hospital
and Medical Center , Englewood , NJ , USA
Joshua B. Kayser , MD, MPH, MBE Division of Pulmonary, Allergy and Critical Care ,
University of Pennsylvania Perelman School of Medicine , Philadelphia , PA , USA
Medical Intensive Care Unit , Cpl. Michael J. Crescenz Veterans Affairs Medical Center ,
Philadelphia , PA , USA
Ruth Kleinpell , PhD, RN, FCCM Center for Clinical Research & Scholarship ,
Rush University Medical Center, Rush University College of Nursing , Chicago , IL , USA
Lisa M. Kodadek , MD Department of Surgery , The Johns Hopkins Hospital ,
Baltimore , MD , USA
Sarah M. Kolnik , MD, MPH General Surgery , University of Washington ,
Seattle , WA , USA
Lindsay E. Kuo , MD, MBA Department of Surgery , Hospital of the University
of Pennsylvania , Philadelphia , PA , USA
Mauricio La Rosa , MD Obstetrics and Gynecology , Pennsylvania Hospital,
University of Pennsylvania Health System , Philadelphia , PA , USA
Richard N. Lesperance , MD Department of Surgery , Vanderbilt University Medical Center ,
Nashville , TN , USA
Pamela A. Lipsett , MD, MHPE Department of Surgery , Johns Hopkins Hospital ,
Baltimore , MD , USA
Christine E. Lotto , MD Department of Surgery, Thomas Jefferson University Hospital,
Philadelphia, PA, USA
Nicole Lucas , BS U.S. Department of State , Offi ce of Medical Services ,
Washington , DC , USA
J. Trent Magruder , MD Division of Cardiac Surgery , Johns Hopkins Hospital ,
Baltimore , MD , USA
Z o ё Maher , MD Division of Trauma and Critical Care, Department of Surgery ,
Temple University Hospital , Philadelphia , PA , USA
Patrick Maluso , MD Department of Surgery , George Washington University ,
Washington , DC , USA
D. Joshua Mancini , MD Department of Surgery , Dartmouth-Hitchcock , Lebanon , NH , USA
Niels Douglas Martin , MD, FACS, FCCM Department of Surgery ,
University of Pennsylvania , Philadelphia , PA , USA
Addison K. May , MD Division of Trauma and Surgical Critical Care,
Department of Surgery , Vanderbilt University Medical Center , Nashville , TN , USA
Kevin W. McConnell , MD Department of General Surgery , Emory University Hospital ,
Atlanta , GA , USA
Maureen McCunn , MD Anesthesiology and Critical Care, R. Adams Cowley Shock
Trauma Center , University of Maryland School of Medicine , Baltimore , MD , USA

xviii
Bryan J. Moore , MD Neurocritical Care , Hospital of the University of Pennsylvania ,
Philadelphia , PA , USA
Nicholas Namias , MD, MBA Department of Surgery , University of Miami Hospital/
Jackson Memorial Hospital/Ryder Trauma Center , Miami , FL , USA
Michael L. Nance , MD Department of Surgery , Surgery Perelman School of Medicine,
Pediatric Trauma Program, Children’s Hospital of Philadelphia , Philadelphia , PA , USA
Lena M. Napolitano , MD Department of Surgery , University of Michigan Health System ,
Ann Arbor , MI , USA
Patrick J. Neligan , MA, MB, FCARCSI, FJFICM Anaesthesia & Intensive Care ,
Galway University Hospitals , Galway , Ireland
Emad Nourollahzadeh , MD, MSc Neurocritical Care and Emergency Neurology ,
Yale New Haven Hospital , New Haven , CT , USA
Olubode Ademola Olufajo , MD, MPH. Department of Surgery , Brigham and Women’s
Hospital , Boston , MA , USA
Corrina Oxford , MD Obstetrics and Gynecology , Pennsylvania Hospital,
University of Pennsylvania Health System , Philadelphia , PA , USA
Neesh Pannu , MD, SM Department of Medicine , University of Alberta ,
Edmonton , Alberta , Canada
Contributors
Pauline K. Park , MD Department of Acute Care Surgery , University of Michigan Hospital ,
Ann Arbor , MI , USA
Jose L. Pascual , MD, PhD, FACS, FRCS (C) Department of Surgery ,
Penn Presbyterian Medical Center , Philadelphia , PA , USA
Greta L. Piper , MD Department of Surgery , NYU Langone Medical Center ,
New York City , NY , USA
Mark-Alan Pizzini , MD Department of Anesthesiology and Critical Care ,
Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA
Interim Associate Chief of Staff , Clinical Operations Corporal Michael J. Crescenz VA
Medical Center, United States Department of Veterans Affairs , Philadelphia , PA , USA
Kimberly M. Ramonell , MD Department of General Surgery , Emory University Hospital ,
Atlanta , GA , USA
Richard P. Ramonell , MD Department of Internal Medicine , Emory University Hospital ,
Atlanta , GA , USA
Benjamin L. Rubin , MD Department of Anesthesiology and Critical Care ,
Perelman School of Medicine, University of Pennsylvania , Philadelphia , PA , USA
Interim Chief of Anesthesiology , Corporal Michael J. Crescenz VA Medical Center, United
States Department of Veterans Affairs , Philadelphia , PA , USA
Mario Rueda , MD Department of Surgery , Johns Hospital , Baltimore , MD , USA
Noelle N. Saillant , MD Department of Surgery, Beth Israel Deaconess Medical Center ,
Boston , MA , USA
Lina Saliba , PharmD, BCPS Department of Pharmacy , Yale-New Haven Hospital ,
New Haven , CT , USA
Ali Salim , MD Division of Trauma, Burn, and Surgical Critical Care ,
Brigham and Women’s Hospital , Boston , MA , USA

Contributors
xix
Michael A. Samotowka , MD, FCCM Trauma/Surgical Critical Care , Cleveland Clinic ,
Cleveland , OH , USA
Babak Sarani , MD, FACS, FCCM Department of Surgery , George Washington University ,
Washington , DC , USA
C. William Schwab , MD, FACS Department of Surgery , Hospital of the University
of Pennsylvania , Philadelphia , PA , USA
Mark J. Seamon , MD Division of Traumatology, Surgical Critical Care, and Emergency
Medicine , Hospital of the University of Pennsylvania , Philadelphia , PA , USA
Aryeh Shander , MD Anesthesiology and Critical Care Medicine , Englewood Hospital
and Medical Center , Englewood , NJ , USA
Carrie A. Sims , MD, MS Division of Trauma, Surgical Critical Care, and Emergency
Surgery, Department of Surgery , University of Pennsylvania , Philadelphia , PA , USA
Stanislaw P. Stawicki , MD, MBA Department of Research and Innovation , St. Luke’s
University Health Network , Bethlehem , PA , USA
Ian J. Stewart , MD Department of Medicine David Grant Medical Center ,
Travis AFB , CA , USA
Jill C. Stoltzfus , PhD Temple University School of Medicine , The Research Institute,
St. Luke’s University Health Network , Bethlehem , PA , USA
Beth E. Taylor , DCN, RD, CNSC, FCCM Food and Nutrition , Barnes-Jewish Hospital ,
St. Louis , MO , USA
Ronald Tesoriero , MD, FACS. Surgical Critical Care and Acute Care Surgery Fellowship ,
R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine ,
Baltimore , MD , USA
Samuel A. Tisherman , MD, FACS, FCCM Surgical Intensive Care Unit ,
R. Adams Cowley Shock Trauma Center, University of Maryland Medical Center ,
Baltimore , MD , USA
Christine C. Toevs , MD Department of Surgery, Terre Haute Regional Hospital ,
Terre Haute , IN , USA
Stanley Z. Trooskin , MD Division of General Surgery , Robert Wood Johnson
University Hospital , New Brunswick , NJ , USA
Rutgers Robert Wood Johnson Medical School , New Brunswick , NJ , USA
William A. Walters , MD U.S. Department of State , Offi ce of Medical Services ,
Washington , DC , USA
Michael S. Weinstein , MD, FACS, FCCM Department of Surgery ,
Thomas Jefferson University Hospital , Philadelphia , PA , USA
Nicole Lena Werner , MD, MS Department of Surgery , University of Michigan
Health System , Ann Arbor , MI , USA
Glenn JR Whitman , MD Division of Cardiac Surgery , Johns Hopkins Hospital ,
Baltimore , MD , USA
Jed Wolpaw , MD, MEd Anesthesiology and Critical Care Medicine ,
Johns Hopkins Hospital , Baltimore , MD , USA

Pain, Agitation, Delirium, and Immobility in the ICU
Juliane Jablonski
1
Introduction
Historically in critical care practice, patients were deeply
sedated while receiving mechanical ventilation. This practice developed as a necessary need for patients to maintain
synchrony with older versions of mechanical ventilators [
Along with signifi cant technological advancements in respiratory therapy, a discriminatory approach is prudent in determining when critically ill patients have a clinical indication
for continuous, deep sedation, such as refractory intracranial
hypertension or certain types of severe acute respiratory failure. Sedation requirements can vary between patients
depending on clinical circumstances; however, targeting
lighter levels of sedation has been shown to lead to better
patient outcomes [ 2 – 7 ].
Current pain, agitation, and delirium (PAD) evidencebased guidelines from the Society of Critical Care Medicine
(SCCM) direct the practice of targeted “light” sedation,
incorporating an analgesia-fi rst approach, spontaneous
awakening trials, the judicious use of non-benzodiazepine
sedatives for symptoms refractory to analgesia, and nonpharmacologic means to alleviate discomfort and minimize
delirium [ 7 ]. Translating evidence into daily practice can be
challenging. Using patient-centered approaches that aim to
empower patients and their surrogates to express their symptoms more precisely, the potential exists to simultaneously
relieve unintentional suffering and improve ICU outcomes.
The Institute for Healthcare (IHI) developed the concept of
practice bundles to help providers deliver the best care for
patients. Bundles are small, straightforward sets of evidencebased practices, when performed collectively and reliably
have been shown to improve patient outcomes. Past examples include central line insertion and ventilator bundles [ 8 ].
J. Jablonski , DNP, RN, CCRN, CCNS
Surgical Critical Care , Hospital of the University of Pennsylvania ,
Philadelphia , PA 19104 , USA
Juliane.Jablonski@uphs.upenn.edu
e-mail:
1 ].
The “ABCDEF bundle” is a mnemonic for a structure that
can be used to operationalize the SCCM PAD guidelines into
clinical practice (see Table 1.1 ). The ABCDEF bundle is evi-
dence based and aimed to promote the best patient outcomes
[
9 , 10 ]. The “A” is to assess, prevent, and manage pain fi rst.
The “B” represents coordination of spontaneous awakening
trials and spontaneous breathing trials. The “C” is for appropriate choice and titration of sedation and analgesia. The “D”
is for the assessment, prevention, and management of delirium. The “E” is for early mobility and exercise. The “F” is
for family engagement and empowerment. Each concept has
a scientifi c background that will be discussed in detail
throughout this chapter.
Research Background
Thomas Petty, a research pioneer in pulmonary medicine,
and past president of the American College of Physicians,
wrote in a 1998 article entitled Suspended life or extending
death , “what I see these days are paralyzed, sedated patients,
lying without motion, appearing to be dead except for monitors that tell me otherwise” [ 11 ]. This quote represents Dr.
Petty’s recognition and intellectual inquiry of critical care
practice that enhances deep sedation and prolonged bed rest.
At the same time, research by Kollef et al. [ 12 ] showed an
association of continuous sedative infusions with prolongation of mechanical ventilation [ 12 ]. This study set the foun-
dation for a multitude of high-quality randomized controlled
trials that continue to lead current practice changes in the
management of pain, agitation, and delirium in critically ill
patients.
Kress et al. [ 2 ] conducted the landmark randomized con-
trolled trial that investigated the effects of decreased sedative
use in 128 medical ICU patients and the fi rst experimental
research design to study an intervention called a “spontaneous awakening trial” [ 2 ]. The intervention required the spon-
taneous stopping of all continuous sedative infusions
autonomously by the clinical nurse, once a day, to evaluate
© Springer International Publishing Switzerland 2016
N.D. Martin, L.J. Kaplan (eds.), Principles of Adult Surgical Critical Care, DOI 10.1007/978-3-319-33341-0_1
1

2
Table 1.1 Society of Critical Care Medicine: ABCDEF bundle
A Assess prevent and manage pain
B Both spontaneous awakening trials and spontaneous breathing trials to achieve light sedation levels and weaning from mechanical
ventilation
C Choice of analgesia and sedation
D Delirium assessment, prevention, and management
E Early mobility and exercise
F Family engagement and empowerment
J. Jablonski
the patient’s need for continued infusion of sedatives. If the
patient did not tolerate the removal of sedation as evident by
hemodynamic instability, or extreme agitation with risk to
safety, then the medication was restarted at half the previous
dose. In this trial the use of spontaneous awakening trials
was shown to decrease cumulative doses of sedative medications, which resulted in 2.4 days less of mechanical ventilation and 3.5 days less in ICU length of stay. Unplanned
extubations (i.e., premature removal of device) were the
same in each study group.
In follow-up to the Kress et al. [ 2 ] study, Girard et al. [ 3 ]
conducted a randomized controlled trial that combined the
coordinated interventions of “spontaneous awakening trials”
and “spontaneous breathing trials”. All continuous sedatives
were stopped once a day, and the patients were trialed on
minimal ventilator support using “pressure support” to assess
for breathing effort and effi ciency [ 3 ]. This study is well
known as the ABC wake-up and breathe trial because the
“A” represents spontaneous awakening trials, the “B” represents spontaneous breathing trials, and the “C” represents the
coordination of the interventions. Similar to results shown by
Kress et al. [ 2 ], this study showed less cumulative use of ben-
zodiazepines, 3.1 higher ventilator-free days, and a 4-day
decrease in ICU length of stay in patients who received the
intervention. There were more patients in the intervention
group with unplanned extubations. The number of patients
who required re-intubation, however, was similar between
groups suggesting that the patients with unplanned extubations may have had a delay in assessment for earlier removal
of the endotracheal tube.
In 2009, Schweickert et al. studied the connection between
sedation, delirium, and immobility in ICU mechanically
ventilated patients [ 4 ]. This was a multicenter, randomized
controlled study that evaluated the use of spontaneous awakening trials, spontaneous breathing trials, and the outcomes
of aggressive early physical activity of mechanically ventilated ICU patients. Patients with aggressive therapy received
physical and occupational therapy 1.5 days after starting
mechanical ventilation treatment. The control group received
the standard physical and occupational therapy that started
7.4 days after starting mechanical ventilation treatment.
Patients in the intervention group had 2 days less of delirium
and 2.7 days less of mechanical ventilation. No unplanned
extubations were encountered in this study. Fifty-nine per-
cent of patients in the intervention group compared with
35 % in the control group returned to their baseline functional status at hospital discharge. The authors concluded
that sedative-induced immobility is a preventable contributor
to ICU-acquired weaknesses.
Analgo-sedation is a strategy of using only pain medication for sedation, without benzodiazepines, to provide comfort for mechanically ventilated patients. In 2010, Strom
et al. conducted a randomized controlled trial evaluating the
effect of a “no-sedation” ICU protocol [ 5 ]. This was the fi rst
trial to compare the use of intermittent opioid and shortacting hypnotic agents in a benzodiazepine-free sedation
protocol. The control group received continuous short-acting
hypnotic agents followed by continuous infusions of benzodiazepines and intermittent morphine. The no- benzodiazepine
group had 4.2 more ventilator-free days, 9.7 fewer ICU days,
and 24 fewer total hospital days. There was no difference in
unplanned extubations between groups. In this study, additional resource persons acted as patient sitters and were used
throughout the study for providing comfort to the patients
and may have served as medical monitors to trigger nursing
intervention.
In 2012, a randomized controlled trial compared the use
of a sedation protocol with spontaneous awakening trials to a
control group without the use of spontaneous awakening trials [ 6 ]. The intervention group received less benzodiazepines
and opioids, but the overall results show no difference in
days of mechanical ventilation, rates of delirium, or length of
ICU stay. There was no signifi cant difference in unplanned
extubation rates between groups. A subgroup analysis of the
trauma and surgical population resulted in an average of
7 days less on mechanical ventilation. A signifi cant weakness in the study is that the stated adherence to the sedation
protocol with spontaneous awakening trials was only 72 %.
An important clinical fi nding from the study was that
although spontaneous awakening trials were not strictly
adhered to, a focus on a structured process for sedation
choice in the ICU resulted in lower cumulative amounts of
sedative in both patient groups.
Augustus and Ho [ 13 ] published a review of randomized
controlled trials comparing a practice that uses continuous
sedative infusions combined with daily spontaneous awakening trials to a practice that uses continuous sedative infusions
and a physician-driven daily decreases in the sedative infu-

1 Pain, Agitation, Delirium, and Immobility in the ICU
3
sions as desired. The review includes fi ve studies and a total
of 699 patients in the meta-analysis [
13 ]. The summary of the
meta-analysis concludes there are similar reductions in cumulative sedative exposure, and no signifi cant difference in the
ventilator days, or ICU length of stay between the groups. In
conclusion, either interventions of using spontaneous awakening trials or targeted light sedation strategies are shown to
reduce sedative exposure and therefore may reduce the complications of the cumulative effects of oversedation.
The challenge of any practice protocol is translation
within the clinical setting. National survey data have demonstrated that many providers identify the availability of practice guidelines and sedation protocols within their institutions
but self-report challenges of low adherence, inconsistent use
of ICU assessment tools, and gaps in communication
between caregivers [ 1 , 14 ]. Only 60 % of critical care units in
the USA report instituting a protocol for sedation and analgesia, and those with protocols self-report variable compliance [ 15 , 16 ].
One example of a descriptive study includes the distribution of surveys to 41 North American hospitals and the
American Thoracic Society e-mail database [ 17 ]. Eighty-
eight percent of hospitals report using validated sedation
assessment tools, and only 50 % use validated delirium
screening tools. Research shows that despite the reported use
of validated sedation tools, clinicians typically prescribe target sedation levels only 24.9 % of the time, and only 34.7 %
of the patients actually met the prescribed target [ 17 , 18 ].
Physician and nursing assessment behaviors interestingly
show that even when patients are minimally arousable, these
patients are being judged as oversedated only 2.6 % of the
time [ 18 ]. Personal beliefs about adequate sedation have
been described to effect actual provider choices in medication and the desired level of sedation of the mechanically
ventilated patients [ 14 , 19 – 21 ].
Pain
Adult ICU patients routinely experience pain not only related
to surgical procedures but during routine nursing care and at
rest [ 25 – 27 ]. All healthcare professionals should be patient
advocates for effective pain control. The “A” in the ABCDEF
bundle exemplifi es the importance of prioritizing pain management for all critically ill patients. For patients with a deep
level of sedation, assessment for pain and delirium is limited,
leading to a potential delay in recognition and treatment [ 1 ,
28 , 29 ]. This is important because unrecognized, uncon-
trolled pain has been shown to be a risk factor for the development of delirium, and both early ICU deep sedation levels
and delirium have been shown to be predictors of mortality
[ 29 – 31 ].
Vital signs should not be used alone as an indicator of
pain but are a cue to continue with an in-depth evaluation
[ 27 , 32 ]. Because pain is subjective by nature, patient self-
report of pain level using a numeric pain score (NPS) is considered the gold standard of practice. When patients are
unable to self-report pain, the most valid and reliable behavioral scales for monitoring of pain are the Critical Care Pain
Observation Tool (CPOT) and the Behavioral Pain Score
(BPS) (see Tables 1.2 and 1.3 ). According to the SCCM
PAD guidelines, the CPOT and the BPS have good interrater reliability, discriminant validity, and criterion validity
when evaluated against four other pain scales. A CPOT
score of greater than two has a sensitivity of 86 % and specifi city of 78 % for predicting the presence of pain [ 32 ]. A
BPS of greater than 5 is the score indicative of the presence
of pain [ 33 ].
Opioids are a mainstay of treatment for pain in critical care
[ 17 ]. A variety of medications may be used as alternatives or
adjuncts to opioid administration. Some examples include
nonsteroidal anti-infl ammatory drugs, acetaminophen, or
anticonvulsants [ 25 ]. Non-pharmacological complimentary
Pain, Agitation, and Delirium Assessment Scales
Valid and reliable tools are recommended for the evaluation
of pain, agitation, and delirium [ 7 ]. Multiple research proto-
cols using validated pain and sedation scales with targeted
“light levels” of sedation have been shown to maintain
patient comfort while decreasing practice variation and
cumulative sedative exposure [ 22 – 24 ]. Using assessment
tools decreases subjective evaluation and allows for an objective framework when assessing pain, agitation, and delirium.
The use of a common language allows for providers to promote goal-directed therapy. Similar to titrating medications
for blood pressure and mean arterial blood pressure (MAP)
goals, valid and reliable tools for pain, agitation, and delirium should guide pharmacologic treatment parameters.
Table 1.2 Behavioral Pain Scale (BPS); range 0–12, goal ≤5
Items Description Score
Facial expression Relaxed 1
Partially tightened (eyelids lowered) 2
Fully tightened (eyelid closing) 3
Grimace 4
Upper limbs No movement 1
Partially bent 2
Fully bent with fi nger fl exion 3
Permanently retracted 4
Compliance with
mechanical
ventilation
Reproduced with permission from Payen et al. [
Tolerating movement 1
Coughing but mostly tolerating
ventilation
Fighting ventilator 3
Unable to control ventilation 4
33 ]
2

4
J. Jablonski
interventions may include music or relaxation therapies; pet
therapy, massage, acupressure, acupuncture, and aromatherapy are underexplored in the ICU by comparison.
Agitation-Sedation
Providers commonly use the word “agitation” to describe
hyperactive patient behaviors [ 34 ]. Synonyms include
disquiet and unrest. In the ICU, “agitation” covers a
broad range of patient signs and symptoms from mildly
restless behavior to dangerously thrashing about in the
Table 1.3 Components of the Critical Care Pain Observation Tool
(CPOT); range 0–8, goal ≤3
Indicator Score
Facial expression Relaxed, neutral = 0
Tense = 1
Grimacing = 2
Body movements Absence of movements = 0
Protection = 1
Restlessness = 2
Muscle tension Relaxed = 0
Evaluated by passive
fl exion and extension of
upper extremities
Compliance with the
ventilator (intubated
patients)
Vocalization (extubated
patients)
Modifi ed from Gelinas and Johnston [
Tense, rigid = 1
Very tense or rigid = 2
Tolerating ventilator or movement = 0
Coughing but tolerating = 1
Fighting ventilator = 2
Talking in normal tone or no sound = 0
Sighing, moaning = 1
Crying out, sobbing = 2
27 ]
bed. It is important to adopt a standard validated tool for
assessing a patient’s level of agitation and sedation. This
will allow for a common taxonomy when describing
patient behavior and assist in developing an appropriate
treatment plan.
The Richmond Agitation-Sedation Scale (RASS) [
and the Riker Sedation-Agitation Scale (SAS) [
36 – 38 ] are
35 ]
considered the most valid and reliable scales for assessing
quality and depth of sedation in ICU patients (Table 1.4 ).
According to the SCCM PAD guidelines, the RASS and the
SAS yield the highest psychometric scores when reviewed
against eight other subjective sedation scales reported in the
literature [ 7 ]. Psychometric scores are based upon content
validation, inter-rater reliability, discriminant validation,
feasibility and directive of use, and relevance in clinical
practice for goal-directed therapy. The goal of an agitationsedation scale is to evaluate level of consciousness, but there
is a limitation in determining the presence of acute
delirium.
Delirium
In 2001, two ICU delirium assessment tools called the
Confusion Assessment Method for the ICU (CAM-ICU)
[ 39 ] and the Intensive Care Delirium Screening Checklist
(ICDSC) [ 40 ] gained recognition. Ely et al. from Vanderbilt
University conducted the original validation study for the
CAM-ICU [ 39 ] (see Fig. 1.1 ). Bergeron et al. from the
University of Montreal conducted the original validation
study for the ICDSC tool [ 40 ] (see Fig. 1.2 ). Currently there
are a total of nine validation studies for the CAM-ICU with
Table 1.4 Comparison of the RASS and the SAS
Richmond Agitation-Sedation Scale (RASS) [ 35 ] Riker Sedation-Agitation Scale (SAS) [ 36 ]
Agitation (4) Combative, violent, immediate danger to self (7) Dangerous, pulling at ET tube, trying to remove
catheters, climbing over bedrail, striking at staff,
thrashing side to side
(3) Very agitated pulls to remove tubes or catheters; aggressive (6) Very agitated requiring restraint and frequent
reminding of limits, biting ETT
(2) Agitated frequent non-purposeful movement, fi ghts ventilator (5) Agitated anxious or physically agitated, calms
(1) Restless anxious, apprehensive, movements not aggressive
Awake and calm (0) Spontaneously pays attention to caregiver (4) Calm and cooperative easily arousable, follows
(−1) Drowsy but sustained eye contact ≥10 s
Sedation (−2) Light sedation briefl y awakens to voice (eyes open and contact
<10 s
(−3) Moderate sedation movement or eye opening to voice (no eye
contact)
(−4) Deep sedation no response to voice but movement or eye
opening to physical stimulus
(−5) Unarousable (1) Unarousable
No response to voice or physical stimulus Minimal or no response to noxious stimuli, does
to verbal instructions
commands
(3) Sedated diffi cult to arouse but awakens to verbal
stimuli or gentle shaking, follows simple
commands but drifts off again
(2) Very sedated arouses to physical stimuli but
does not communicate or follow commands,
may move spontaneously
not communicate or follow commands
Соседние файлы в папке Библиотека им академика М.И. Перельмана
